Benzinga · Feb 17, 2026
NYSE · LUCY
Innovative Eyewear, Inc.
Healthcare · Medical - Instruments & Supplies
$0.95
Up+$0.01 (+0.92%)
Updated Aug 31, 2026, 10:09 AM
SID Score
4.3/10
Composite research score
Smart Money
—
Institutional and insider signal
- Market cap
- 7.23M
- P/E ratio
- -0
- Dividend yield
- 0.00%
- 52-week range
- $0.65 – $2.24
- Volume
- 1.15M
- Avg. volume
- 611.34K
Price performance
LUCY price history
1M range · 20 trading sessions · Daily adjusted prices
LUCY closed at $0.95 after 20 trading sessions, up 39.09% for the selected period.
- Last close
- $0.95
- Period change
- +39.09%
- Period low
- $0.68
- Period high
- $1.13
View OHLC price history
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Aug 28, 2026 | $0.935 | $0.9944 | $0.935 | $0.95 | 1.15M |
| Aug 27, 2026 | $1.20 | $1.27 | $0.88 | $0.9413 | 5.8M |
| Aug 26, 2026 | $1.08 | $1.25 | $1.08 | $1.13 | 5.2M |
| Aug 25, 2026 | $1.04 | $1.20 | $1.0183 | $1.07 | 6.75M |
| Aug 24, 2026 | $0.993 | $1.30 | $0.8775 | $1.12 | 195.37M |
| Aug 21, 2026 | $0.6841 | $0.6928 | $0.6703 | $0.6839 | 88.52K |
| Aug 20, 2026 | $0.6807 | $0.7097 | $0.6703 | $0.6845 | 170.4K |
| Aug 19, 2026 | $0.704 | $0.7195 | $0.665 | $0.681 | 241.83K |
| Aug 18, 2026 | $0.7281 | $0.7281 | $0.6909 | $0.711 | 98.74K |
| Aug 17, 2026 | $0.72 | $0.735 | $0.7003 | $0.7003 | 119.92K |
| Aug 14, 2026 | $0.74 | $0.75 | $0.69 | $0.7342 | 308.05K |
| Aug 13, 2026 | $0.721 | $0.7696 | $0.721 | $0.7543 | 231.57K |
| Aug 12, 2026 | $0.7039 | $0.7297 | $0.6898 | $0.7251 | 193.15K |
| Aug 11, 2026 | $0.701 | $0.73 | $0.6864 | $0.6985 | 106.4K |
| Aug 10, 2026 | $0.7203 | $0.7298 | $0.693 | $0.697 | 93.91K |
| Aug 7, 2026 | $0.72 | $0.74 | $0.7001 | $0.7201 | 83.73K |
| Aug 6, 2026 | $0.71 | $0.74 | $0.69 | $0.719 | 164.48K |
| Aug 5, 2026 | $0.717 | $0.73 | $0.70 | $0.7135 | 105.22K |
| Aug 4, 2026 | $0.70 | $0.75 | $0.683 | $0.7424 | 530.03K |
| Aug 3, 2026 | $0.70 | $0.7298 | $0.6821 | $0.683 | 79.87K |
Latest LUCY news
The latest Smart Investors Daily articles mentioning LUCY.
Stock researchCompany · Overview
LUCY research
Overview
Company profile and research snapshot.
Company profile
Innovative Eyewear Inc is engaged in developing and selling eyeglasses and sunglasses, which are designed to allow customers to remain connected to their digital lives, while also offering prescription eyewear and sun protection. Its products include Lucyd Lyte, Nautica, Eddie Bauer, Lucyd Armor line, and Reebok.
Visit company websiteAnalyst outlook
Consensus and target data currently published for this company.
- Consensus
- Buy
- Average target
- $3.06
- Implied upside
- —
- Analysts
- 7
| Date | Firm | Rating | Target |
|---|---|---|---|
| Jun 3, 2026 | Maxim Group | Hold | — |
| Mar 26, 2024 | Maxim Group | Buy | — |
| Sep 11, 2023 | Maxim Group | Buy | — |
News briefing
No generated briefing is available yet.
prnewswire.com · Dec 11, 2025
Innovative Eyewear, Inc. Announces New Reebok® Smart Eyewear for Gym and Indoor Sports
MIAMI , Dec. 11, 2025 /PRNewswire/ -- Innovative Eyewear, Inc. ("Innovative Eyewear" or the "Company") (NASDAQ: LUCY; LUCYW), the manufacturer of smart eyewear under the Lucyd®, Lucyd Armor®, Reebok®, Eddie Bauer ® and Nautica® brands, is pleased to announce that it has launched two new, light-adaptive sport smartglasses in its cutting-edge Reebok Powered by Lucyd Smart Eyewear collection. These new variants of the Octane and Nitrous frames are designed for use in the gym and indoor sport.
AI research layers
Interpretive context generated from the platform’s current data sources.
No results
AI research layers have not been published yet.

